Cargando…
CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications
CD44 is a heavily glycosylated membrane receptor playing a key role in cell adhesion, signal transduction and cytoskeleton remodelling. It is also one of the most studied glycoproteins in cancer, frequently explored for stem cell identification, and associated with chemoresistance and metastasis. Ho...
Autores principales: | Azevedo, Rita, Gaiteiro, Cristiana, Peixoto, Andreia, Relvas-Santos, Marta, Lima, Luís, Santos, Lúcio Lara, Ferreira, José Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020424/ https://www.ncbi.nlm.nih.gov/pubmed/29983670 http://dx.doi.org/10.1186/s12014-018-9198-9 |
Ejemplares similares
-
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
por: Gaiteiro, Cristiana, et al.
Publicado: (2022) -
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
por: Azevedo, Rita, et al.
Publicado: (2017) -
Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
por: Peixoto, Andreia, et al.
Publicado: (2019) -
Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies
por: Lima, Luís, et al.
Publicado: (2016) -
Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells
por: Fernandes, Elisabete, et al.
Publicado: (2020)